FTC Approves Sublicense for Synacthen Depot Submitted by Mallinckrodt ARD Inc.
Date
The Federal Trade Commission has approved a sublicense submitted by Mallinckrodt ARD Inc. granting West Therapeutic Development, LLC certain rights to develop and market the specialty drug Synacthen...